Reply to Can Pindolol Really Enhance Antidepressant Effect?
J Clin Psychiatry 2011;72(11):1558 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: In his letter to the editor, Prof Terao doubts whether pindolol can enhance, apart from accelerate, the antidepressant effect of selective serotonin reuptake inhibitors (SSRIs).
As correctly stated by Prof Terao, a number needed to treat (NNT) higher than 10 is not clinically meaningful, and therefore an NNT of 13 regarding late clinical response is not relevant. The results of our meta-analysis show that pindolol accelerates antidepressant effects within the first 4 weeks, but not for any longer, as previously reported by Ballesteros and Callado1 and Whale et al.